A realistic two-strain model for MERS-CoV infection uncovers the high risk for epidemic propagation

PLoS Negl Trop Dis. 2020 Feb 14;14(2):e0008065. doi: 10.1371/journal.pntd.0008065. eCollection 2020 Feb.

Abstract

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) causes severe acute respiratory illness with a case fatality rate (CFR) of 35,5%. The highest number of MERS-CoV cases are from Saudi-Arabia, the major worldwide hotspot for this disease. In the absence of neither effective treatment nor a ready-to-use vaccine and with yet an incomplete understanding of its epidemiological cycle, prevention and containment measures can be derived from mathematical models of disease epidemiology. We constructed 2-strain models to predict past outbreaks in the interval 2012-2016 and derive key epidemiological information for Macca, Madina and Riyadh. We approached variability in infection through three different disease incidence functions capturing social behavior in response to an epidemic (e.g. Bilinear, BL; Non-monotone, NM; and Saturated, SAT models). The best model combination successfully anticipated the total number of MERS-CoV clinical cases for the 2015-2016 season and accurately predicted both the number of cases at the peak of seasonal incidence and the overall shape of the epidemic cycle. The evolution in the basic reproduction number (R0) warns that MERS-CoV may easily take an epidemic form. The best model correctly captures this feature, indicating a high epidemic risk (1≤R0≤2,5) in Riyadh and Macca and confirming the alleged co-circulation of more than one strain. Accurate predictions of the future MERS-CoV peak week, as well as the number of cases at the peak are now possible. These results indicate public health agencies should be aware that measures for strict containment are urgently needed before new epidemics take off in the region.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carrier State
  • Computer Simulation
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / virology*
  • Epidemics*
  • Humans
  • Middle East Respiratory Syndrome Coronavirus*
  • Models, Biological*
  • Risk Factors

Grants and funding

I.G. was supported by the research fellowship from University Grants Commission (https://www.ugc.ac.in/), Government of India. X.R. acknowledges the support of a fellowship by the PERIS PICAT project SLT002/16/00466 (peris@gencat.cat| http://canalsalut.gencat.cat) from the Catalan Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.